Abstract: A vapor supply apparatus is described. The apparatus stably supplies vapor to a process chamber when the vapor pressure of the material is lower than the process pressure. The apparatus includes a supply container accommodating a solid or a liquid having a vapor pressure which is lower than the process pressure. The vapor may be generated in the supply container from a liquid or from a solid. A buffer tank is interposed between the supply container and the process chamber and into which the vapor from the container is introduced by reducing pressure. The apparatus includes a mechanism for pressurizing the buffer tank and pressure-feeding the vapor to the process chamber.

Abstract: In a manufacturing method for a sintered body, a mold device including a die, first and second punches, first and second spacers, first and second rams, and a plurality of thermal resistors is used. The manufacturing method includes an operation of loading raw material powder into a cavity of the die and then sintering the raw material powder, while pressing and molding the raw material powder in the uniaxial direction using the first and second punches, to form a sintered body and an operation of cooling the formed sintered body. In the operation of cooling the formed sintered body, an acoustic emission (AE) waveform is detected from the formed sintered body, and it is determined whether a crack has occurred in the formed sintered body using the detected AE waveform.

Abstract: An information processing device includes a buffer that stores data blocks of a plurality of flows and from which the data blocks are sequentially read; a processor coupled to the buffer and configured to: monitor an input rate that is a sum of data amounts of the plurality of flows input to the buffer per unit of time, and suppress flowing of a data block into the buffer for one or more of the plurality of flows based on a result of monitoring the input rate.

Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.

Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: In a point-to-multipoint network of an optical line terminal (OLT) and multiple optical network units (ONUS) wherein each ONU is enabled to send a signal only within a time period enabled for the ONU, the OLT (or a system installed therein) identifies a defective one of the ONUs. For each of a given series of time periods, the OLT measures an optical reception level of an optical fiber signal in the time period. The OLT stores, in advance, in a table at least the reception level of a received signal from each ONU in association with the ONU. The reception level is measured in a normal state where signals from the ONUs are exclusively received. For each of the given series of time periods, the OLT decides whether a signal from one of the ONUs associated with the time period is exclusively received with no collision with any other signal.

Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.

Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.

Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: In a point-to-multipoint network of an optical line terminal (OLT) and multiple optical network units (ONUS) wherein each ONU is enabled to send a signal only within a time period enabled for the ONU, the OLT (or a system installed therein) identifies a defective one of the ONUs. For each of a given series of time periods, the OLT measures an optical reception level of an optical fiber signal in the time period. The OLT stores, in advance, in a table at least the reception level of a received signal from each ONU in association with the ONU. The reception level is measured in a normal state where signals from the ONUs are exclusively received. For each of the given series of time periods, the OLT decides whether a signal from one of the ONUs associated with the time period is exclusively received with no collision with any other signal.

Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: The hoses connected to parts of a photosensitive material processor, like to a processing tank, are formed from a styrene containing or olefin containing thermoplastic elastomer. Plasticizers such as those found in PVC hoses are not used in the material so cracking does not occur in the portions connecting the hoses to the processing tanks. Further, since it is not necessary to make the connecting portions of the processing tanks out of metal in order to prevent cracking, the manufacturing costs of the processor can be reduced.

Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.

Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.

Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.

Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: This invention regarding the medical measurement apparatus includes an apparatus body capable of being held with a thumb and at least one of the subject testing-fingers, that is, the forefinger, the middle finger, the third finger, the fourth finger; a sensor slot bearing within a sensor in which the sensor slot is open at the side of the apparatus body capable of inserting the testing finger; a switch of the sensor in which the switch is controlled by the thumb and disposed at a prescribed position of the apparatus body; and a display device for indicating the result measured by the sensor in which the display device is arranged at the front surface of the apparatus body.

Abstract: An infrared detector comprising an infrared detector element for generating an electrical signal, a support for the infrared detector element, and a circuit board for receiving the electrical signal from the infrared detector element. The support is formed integrally with the circuit board. The support comprises a matrix of composite material essentially consisting of one of thermosetting resins and thermoplastic resins having a thermal deformation temperature of at least 100.degree. C. and a tensile elastic modulus of at least 100 kgf/mm.sup.2, and of carbon fibers contained in the range of 10 to 40% by weight and dispersed in the matrix. The circuit board is formed with a through-hole having an inner surface processed so as to be electrically conductive.